About Us

HEDEX MEDICAL INC. (hereafter also referred to as the Company) will be a British Columbia-based company that will distribute innovative medical devices through its retail and online channels. The products will be imported from the U.S. and used in treatments such as depression, anxiety, and insomnia. The Company will strive to deliver high-quality products at a great value and provide exceptional customer service in order to maintain positive client relations. HEDEX MEDICAL INC. will ensure that clients are satisfied by offering high-quality devised as well as attentive before- and after-sales services.

HEDEX MEDICAL INC. will secure and operate from a virtual office in Vancouver, British Columbia.

HEDEX MEDICAL INC. was incorporated on May 28, 2020, in British Columbia under the number BC1251605. Ms. Hediyeh Zabihi owns 100% of the Company. Ms. Hediyeh Zabihi is a multi-faceted professional with many years of professional experience and consistent achievements in a management capacity. For this reason, Ms. Hediyeh Zabihi will be essential in leading the Company’s operations and development. She will invest a total of $200,000 in the Company.

In Year 1, the Company will have a total of three employees, including Ms. Hediyeh Zabihi as the Chief Executive Officer, one Sales Manager, and one Customer Service Representative. HEDEX MEDICAL INC.’s employee count will increase to seven by the end of Year 5. Payroll expenses are projected to start at $142,488 in Year 1 and increase to $487,131 in Year 5.

Under the direction of Ms. Hediyeh Zabihi, who possesses the extensive professional experience and proven management skills, HEDEX MEDICAL INC.’s sales are expected to grow from $658,150 in Year 1 to $2,203,202 in Year


Business Description

HEDEX MEDICAL INC. will distribute innovative medical devices through retail and online sales channels. The products will be imported from the U.S. and distributed within Canada. By employing various marketing campaigns to raise brand awareness, HEDEX MEDICAL INC. expects to see an increase in revenues and net profits over the next five years.

The Company’s devices use modern technology for the treatment of conditions such as depression, anxiety, and insomnia in Canada. Also, the technology behind these products has been used in doctor's offices for over 30 years to help people with Post-traumatic Stress Disorder (PTSD). Research studies show up to a 70% reduction in stress in just 30 seconds after using the Company’s devices. HEDEX MEDICAL INC. expects larger demand for its products after the COVID-19 pandemic. In these troubling times, it has never been more important for healthcare providers to be able to manage and triage their patients remotely and without face-to-face interaction. According to Statista, as of May 21, 2020, there had been over 1.3 million people in Canada tested for COVID-19, with 81,313 confirmed cases. People aged 50 to 59 years have accounted for around 17% of all COVID-19 cases in Canada, with those aged 19 years and younger only accounting for 6%. The disease has been confirmed in every Canadian province or territory, with Quebec and Ontario reporting the highest number of cases. Unsurprisingly, these are also the provinces that have reported the highest number of deaths from COVID-19. As of May 21, there had been a total of around 6,152 deaths from the disease in Canada.

HEDEX MEDICAL INC. will represent U.S. device manufacturers as the sole distributor and develop an end-user customer network. The Company’s commitment to quality, details, and service will provide a competitive advantage over other device distributors. The most prominent suppliers for HEDEX MEDICAL INC. will be Spire Health and Touch Point. The Company has already developed relationships with suppliers that share the Company’s commitment to the customer. Spire Health is the market leader in continuous respiration sensing and high-adherence, patient-friendly ambulatory monitoring. Touch Point has developed twin neuroscientific wearable devices that use patent-pending Bilateral Alternating Stimulation Tactile (BLAST) technology to reduce stress by up to 70% in as few as 30 seconds.

Ms. Hediyeh Zabihi will make all the necessary decisions and develop new business opportunities. She has recognized the potential of the Medical Devices Industry in Canada and therefore has created strong relationships with business partners.

HEDEX MEDICAL INC. will approach each client in the most professional manner and hire experienced professionals who understand the importance of service and efficiency. The Company intends to continuously expand its business partner network and offer products that meet industry standards and market demands.

The professional experience of the key management and high-quality services will be among the many advantages of HEDEX MEDICAL INC.